Skip to content

Cigarette Smoking Among Young Adults

Impact of a Reduced Nicotine Standard on Young Adult Appeal for Menthol and Non-menthol Cigarettes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04340947
Acronym
ENHANCE
Enrollment
171
Registered
2020-04-10
Start date
2021-08-01
Completion date
2024-04-30
Last updated
2025-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking, Smoking Behaviors

Brief summary

This study will examine perceptions and smoking behavior of menthol and non-menthol very low nicotine cigarettes in young adult smokers. The aims are to examine perceptions and smoking behavior in the laboratory and in the natural environment. A separate sub-sample of men and women who identify as LGBTQ2S+ will also be recruited.

Detailed description

This proposal includes three different aspects of assessment for menthol smoking young adults. The laboratory phase includes three separate sessions of laboratory smoking through a machine designed to measure puff behavior; the EMA phase includes 21 days of monitoring smoking behavior and attitudes related to smoking when smoking one's usual brand cigarette, the assigned menthol low nicotine cigarette, and the assigned non-menthol low nicotine cigarette in the participant's natural environment. The order of administration of smoking menthol and non-menthol VLNC will be counterbalanced. There will be a 7-day wash-out period between each 7-day period of using low nicotine cigarettes. The final phase includes a virtual marketplace where participants can purchase and use the research cigarettes in the context of other available tobacco products on the market, or purchase no tobacco products at all. There will be a final assessment, over the phone or in-person, 30-days after the final study visit (at week 8), to assess tobacco use behavior and attitudes about tobacco use. Participants will be enrolled for approximately 9 weeks. Week 1 will consist of smoking one's usual brand of cigarette in the laboratory and then in their home environment for 7-days. Week 2 will consist of smoking the first very low nicotine cigarette in the home environment for 7 days and then in the laboratory. Week three will consist of a 7-day wash-out period where participants can smoke their usual brand again, as they normally would. Week 4 will consist of smoking the second very low nicotine cigarette at home for 7 days and then in the laboratory. Week 5 will consist of returning to the laboratory for a final study visit and complete a hypothetical experimental tobacco marketplace. One month (4 weeks) after the final study visit (week 9), participants will complete a 30-day follow-up of cigarette smoking and other tobacco use behavior.

Interventions

OTHERVery low nicotine cigarette: menthol

Participants will be randomized to smoke either menthol non-menthol flavored very low nicotine cigarettes in their home environment for 7 days and in the laboratory first and then crossed over to receive the opposite intervention. The study consists of two treatment periods of 7 days separated by a 1 week wash-out period

OTHERVery low nicotine cigarette: non-mentol

Participants will be randomized to smoke either menthol non-menthol flavored very low nicotine cigarettes in their home environment for 7 days and in the laboratory first and then crossed over to receive the opposite intervention. The study consists of two treatment periods of 7 days separated by a 1 week wash-out period

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of Oklahoma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 34 Years
Healthy volunteers
Yes

Inclusion criteria

1. Ages18 to 34; 2. Smoke cigarettes somedays or everyday for at least the past 3-months; 3. A strong preference for menthol cigarettes (i.e., smoke menthol \>80% of the time); and 4. Ability to read English at an 8th grade level or higher; 5. No immediate plans to quit smoking.

Exclusion criteria

1. Current use of nicotine replacement therapy (NRT); 2. Pregnant or planning to become pregnant, or currently breastfeeding; 3. Past or current self-reported clinically significant heart disease or hypertension, or other smoking-related disease (by history) that preclude successful study completion; 4. Serious psychiatric disorder; 5. Inability to abstain from nicotine/tobacco products; 6. Strong preference for non-menthol cigarettes (smoke non-menthol \> 80% of the time)

Design outcomes

Primary

MeasureTime frameDescription
Puff TopographyBaseline to week 4total inhalation volume from smoking behavior in the laboratory
Hypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)Assessed during tobacco purchase tasks completed at week 5Purchasing of non-menthol very low nicotine cigarettes in the Experimental Tobacco Marketplace (ETM) task 1 and 2. Product units purchased per cigarette price displayed in the ETM, displayed as milligrams of nicotine. Prices are $0.12, $0.25, $0.5, $1, $2, $4, $8, and $16 per cigarette. Data are presented as units purchased on a log scale, per recommended best practices.
Ratings of Psychological RewardBaseline to week 9Subjective response to smoking, as measured by self-reported psychological reward (scale) of the modified Cigarette Evaluation Scale, administered after smoking. The minimum value is 1 and the maximum value is 7; with 7 indicating greater psychological reward.

Secondary

MeasureTime frameDescription
Exhaled CO BoostBaseline to week 4measures expired alveolar carbon monoxide (CO) level before smoking and after smoking; measured in parts per million (ppm)

Other

MeasureTime frameDescription
Heart RateBaseline to week 4Heart rate is measured as beats per minute (BPM); where higher scores indicate higher heart rate.
Perceived Health Risk ScaleBaseline to week 8This scale measures perceptions of risk from smoking one's usual brand or the very low nicotine cigarettes. Participants completed this questionnaire at the beginning of each in-person smoking visit (after a week of smoking the assigned cigarette at home). The measure has 7 questions. Each question has response options ranging from 1 (very low risk of disease) to 10 (very high risk of disease). Higher scores indicate greater perceived risk. The outcome reflects the total score, divided by 7 (the number of questions)
Change in Cigarette Craving Before and After SmokingBaseline to week 91-item craving measure from the Minnesota Nicotine Withdrawal Scale. Response options range from 0 (none/not at all) to 4 (severe), where 4 indicates higher craving for a cigarette.
Nicotine WithdrawalBaseline to week 9Symptoms of nicotine withdrawal were measured using the Minnesota Nicotine Withdrawal Scale. Response options range from 0=none to 4=severe; where higher scores indicate more severe nicotine withdrawal.

Countries

United States

Participant flow

Recruitment details

N= 171 were eligible and enrolled at the first visit. N=143 people attended Visit 2 to smoke their usual brand (UB) cigarette, and n=139 were randomized to the intervention. After visit 2, the intervention began where people smoked a menthol and non-menthol VLNC (order counterbalanced) in two subsequent visits (VLNC 1 visit, VLNC 2 visit). There was a 7-day washout period between VLNC 1 and VLNC 2 smoking. The experimental tobacco marketplace was the final visit.

Pre-assignment details

This is a within-subjects design. Participants were assigned to both smoke menthol and non-menthol very low nicotine cigarettes in visits 3 and 4 and at home for a week prior to each visit. The order of administration of menthol vs non-menthol flavor was counterbalanced to reduce the impact of order effects. The number of people to start a period may not equal the number who completed the previous period due to loss to follow-up.

Participants by arm

ArmCount
All Study Participants
Participants will smoke menthol flavored very low nicotine cigarettes in their home environment for 7 days. At the end of 7-days, they will also smoke one menthol flavored very low nicotine cigarette in the laboratory. Very low nicotine cigarettes: Participants were randomized to smoke menthol and non-menthol flavored very low nicotine cigarettes in their home environment for 7 days and in the laboratory.
171
Total171

Withdrawals & dropouts

PeriodReasonFG000FG001
7-day Washout PeriodLost to Follow-up54

Baseline characteristics

CharacteristicAll Study Participants
Age, Continuous25.16 years
STANDARD_DEVIATION 4.41
Cigarettes/day8.86 unit of measure cigarettes per day
STANDARD_DEVIATION 6.58
Race/Ethnicity, Customized
Hispanic
22 Participants
Race/Ethnicity, Customized
Non-hispanic Black
22 Participants
Race/Ethnicity, Customized
Non-hispanic other race
25 Participants
Race/Ethnicity, Customized
Non-hispanic white
102 Participants
Region of Enrollment
United States
171 participants
Sex: Female, Male
Female
84 Participants
Sex: Female, Male
Male
87 Participants
Time-to-first cigarette
Smoke within 5 minutes of waking
36 Participants
Time-to-first cigarette
Smoke within 6 or more minutes after waking
134 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 171
other
Total, other adverse events
1 / 171
serious
Total, serious adverse events
0 / 171

Outcome results

Primary

Hypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)

Purchasing of non-menthol very low nicotine cigarettes in the Experimental Tobacco Marketplace (ETM) task 1 and 2. Product units purchased per cigarette price displayed in the ETM, displayed as milligrams of nicotine. Prices are $0.12, $0.25, $0.5, $1, $2, $4, $8, and $16 per cigarette. Data are presented as units purchased on a log scale, per recommended best practices.

Time frame: Assessed during tobacco purchase tasks completed at week 5

Population: We report raw data on number of non-menthol VLNCs purchased at each price.

ArmMeasureGroupValue (MEAN)Dispersion
Usual Brand CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$0.1220.40 log (mg of nicotine)Standard Deviation 36.22
Usual Brand CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$0.2514.44 log (mg of nicotine)Standard Deviation 26.64
Usual Brand CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$0.5010.17 log (mg of nicotine)Standard Deviation 19.25
Usual Brand CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$1.005.68 log (mg of nicotine)Standard Deviation 14.64
Usual Brand CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$2.002.56 log (mg of nicotine)Standard Deviation 7.56
Usual Brand CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$4.001.16 log (mg of nicotine)Standard Deviation 6.04
Usual Brand CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$8.000.44 log (mg of nicotine)Standard Deviation 2.13
Usual Brand CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$16.000.25 log (mg of nicotine)Standard Deviation 1.51
Menthol Very Low Nicotine CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$16.000.02 log (mg of nicotine)Standard Deviation 0.13
Menthol Very Low Nicotine CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$0.126.11 log (mg of nicotine)Standard Deviation 18.38
Menthol Very Low Nicotine CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$2.001.18 log (mg of nicotine)Standard Deviation 6.33
Menthol Very Low Nicotine CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$0.253.66 log (mg of nicotine)Standard Deviation 13.11
Menthol Very Low Nicotine CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$8.000.06 log (mg of nicotine)Standard Deviation 0.43
Menthol Very Low Nicotine CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$0.503.37 log (mg of nicotine)Standard Deviation 12.21
Menthol Very Low Nicotine CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$4.000.34 log (mg of nicotine)Standard Deviation 1.69
Menthol Very Low Nicotine CigaretteHypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)$1.001.68 log (mg of nicotine)Standard Deviation 7.21
Primary

Puff Topography

total inhalation volume from smoking behavior in the laboratory

Time frame: Baseline to week 4

Population: Analysis was restricted to individuals who completed at 2 study visits (of 3 visits). Some individuals were excluded from analysis because of missing smoking data that was not captured by the smoking topography device or several participants who erroneously smoked more than 1 cigarette.

ArmMeasureValue (MEAN)Dispersion
Usual Brand CigarettePuff Topography1108 mLStandard Deviation 1013.7
Menthol Very Low Nicotine CigarettePuff Topography1045.2 mLStandard Deviation 1119.4
Non-menthol Very Low Nicotine CigarettePuff Topography1084.6 mLStandard Deviation 1141
Primary

Ratings of Psychological Reward

Subjective response to smoking, as measured by self-reported psychological reward (scale) of the modified Cigarette Evaluation Scale, administered after smoking. The minimum value is 1 and the maximum value is 7; with 7 indicating greater psychological reward.

Time frame: Baseline to week 9

Population: Population included participants who completed at two study visits and who did not have any missing data on the outcomes

ArmMeasureValue (MEAN)Dispersion
Usual Brand CigaretteRatings of Psychological Reward3.1 score on a scaleStandard Deviation 1.3
Menthol Very Low Nicotine CigaretteRatings of Psychological Reward2.9 score on a scaleStandard Deviation 1.4
Non-menthol Very Low Nicotine CigaretteRatings of Psychological Reward2.3 score on a scaleStandard Deviation 1.3
Secondary

Exhaled CO Boost

measures expired alveolar carbon monoxide (CO) level before smoking and after smoking; measured in parts per million (ppm)

Time frame: Baseline to week 4

Population: Population included individuals who completed at least 2 study visits and who did not have any missing data.

ArmMeasureGroupValue (MEAN)Dispersion
Usual Brand CigaretteExhaled CO BoostBefore smoking4.08 parts per million (ppm)Standard Deviation 5.03
Usual Brand CigaretteExhaled CO BoostAfter smoking9.17 parts per million (ppm)Standard Deviation 9.42
Menthol Very Low Nicotine CigaretteExhaled CO BoostBefore smoking3.72 parts per million (ppm)Standard Deviation 4.16
Menthol Very Low Nicotine CigaretteExhaled CO BoostAfter smoking7.65 parts per million (ppm)Standard Deviation 6.84
Non-menthol Very Low Nicotine CigaretteExhaled CO BoostBefore smoking3.9 parts per million (ppm)Standard Deviation 5.12
Non-menthol Very Low Nicotine CigaretteExhaled CO BoostAfter smoking6.79 parts per million (ppm)Standard Deviation 6.8
Other Pre-specified

Change in Cigarette Craving Before and After Smoking

1-item craving measure from the Minnesota Nicotine Withdrawal Scale. Response options range from 0 (none/not at all) to 4 (severe), where 4 indicates higher craving for a cigarette.

Time frame: Baseline to week 9

Population: Population included individuals who completed at least 2 study visits and who did not have any missing data.

ArmMeasureValue (MEAN)Dispersion
Usual Brand CigaretteChange in Cigarette Craving Before and After Smoking2.18 score on a scaleStandard Deviation 1.38
Menthol Very Low Nicotine CigaretteChange in Cigarette Craving Before and After Smoking1.92 score on a scaleStandard Deviation 1.43
Non-menthol Very Low Nicotine CigaretteChange in Cigarette Craving Before and After Smoking1.85 score on a scaleStandard Deviation 1.33
Other Pre-specified

Heart Rate

Heart rate is measured as beats per minute (BPM); where higher scores indicate higher heart rate.

Time frame: Baseline to week 4

Population: Population included individuals who completed at least 2 study visits and who did not have any missing data.

ArmMeasureGroupValue (MEAN)Dispersion
Usual Brand CigaretteHeart RateAfter smoking85.73 beats per minuteStandard Deviation 14.06
Usual Brand CigaretteHeart RateBefore smoking76.85 beats per minuteStandard Deviation 12.38
Menthol Very Low Nicotine CigaretteHeart RateBefore smoking75.03 beats per minuteStandard Deviation 13.62
Menthol Very Low Nicotine CigaretteHeart RateAfter smoking75.72 beats per minuteStandard Deviation 14.38
Non-menthol Very Low Nicotine CigaretteHeart RateBefore smoking77.25 beats per minuteStandard Deviation 12.77
Non-menthol Very Low Nicotine CigaretteHeart RateAfter smoking76.42 beats per minuteStandard Deviation 13
Other Pre-specified

Nicotine Withdrawal

Symptoms of nicotine withdrawal were measured using the Minnesota Nicotine Withdrawal Scale. Response options range from 0=none to 4=severe; where higher scores indicate more severe nicotine withdrawal.

Time frame: Baseline to week 9

Population: Population included individuals who completed at least 2 study visits and who did not have any missing data.

ArmMeasureGroupValue (MEAN)Dispersion
Usual Brand CigaretteNicotine WithdrawalBefore smoking0.54 score on a scaleStandard Deviation 0.47
Usual Brand CigaretteNicotine WithdrawalAfter smoking.26 score on a scaleStandard Deviation 0.29
Menthol Very Low Nicotine CigaretteNicotine WithdrawalBefore smoking0.48 score on a scaleStandard Deviation 0.41
Menthol Very Low Nicotine CigaretteNicotine WithdrawalAfter smoking.27 score on a scaleStandard Deviation 0.3
Non-menthol Very Low Nicotine CigaretteNicotine WithdrawalBefore smoking0.47 score on a scaleStandard Deviation 0.45
Non-menthol Very Low Nicotine CigaretteNicotine WithdrawalAfter smoking.30 score on a scaleStandard Deviation 0.29
Other Pre-specified

Perceived Health Risk Scale

This scale measures perceptions of risk from smoking one's usual brand or the very low nicotine cigarettes. Participants completed this questionnaire at the beginning of each in-person smoking visit (after a week of smoking the assigned cigarette at home). The measure has 7 questions. Each question has response options ranging from 1 (very low risk of disease) to 10 (very high risk of disease). Higher scores indicate greater perceived risk. The outcome reflects the total score, divided by 7 (the number of questions)

Time frame: Baseline to week 8

Population: Population includes individuals who attended the visit and who completed the questionnaire on perceived health risks of the cigarette flavor they smoked in the previous week.

ArmMeasureValue (MEAN)Dispersion
Usual Brand CigarettePerceived Health Risk Scale5.30 units on a scaleStandard Deviation 2.2
Menthol Very Low Nicotine CigarettePerceived Health Risk Scale4.45 units on a scaleStandard Deviation 2.28
Non-menthol Very Low Nicotine CigarettePerceived Health Risk Scale4.45 units on a scaleStandard Deviation 2.18

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026